FINEORG: Investor Presentation - May 2026
Fine Organic Industries released its May 2026 Investor Presentation. Strategic expansions include a USD 1.12 million (₹9.6 crore) investment in Fine Organics Americas LLC (USA), AED 200,000 (₹49.48 lakhs) in Fine Organics FZE (Dubai, UAE), and THB 22.50 million (₹6.17 crores) in its Thailand JV. They will acquire up to 80% of Oleofine Organics Sdn. Bhd. (Malaysia) for approximately RM 34.210 million (₹83 crores).
The investor presentation provides insights into the company's strategic direction and financial performance, which can have a moderate impact on investor perception and stock valuation.
The announcement is an investor presentation, providing factual information about the company's performance, strategy, and expansions without expressing a strong positive or negative outlook.
Fine Organic Industries Limited has released its Investor Presentation for May 2026, as disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation, accessible on the company's website, provides insights into the company's vision, mission, and expertise in oleochemistry. FINEORG is positioned as an established international player in specialty additives, emphasizing green and sustainable products. They focus on developing specialty green additives and ingredients for diverse end-user applications and expanding research and manufacturing infrastructure. The company has a strong R&D focus with more than 40 scientists and technicians. They have a diversified product portfolio, serving multiple end-users across food, polymers, cosmetics, and coatings.
The company's strategic expansions include the incorporation of Fine Organics Americas LLC in the United States with an equity investment of USD 1.12 million (approximately ₹9.6 crore), Fine Organics FZE in Dubai, UAE, with an equity infusion of AED 200,000 (approximately ₹49.48 lakhs), and equity infusion of THB 22.50 million (₹6.17 crores) in its Joint Venture in Thailand. The Board of Directors has approved the proposed acquisition of up to 80% shares of Oleofine Organics Sdn. Bhd. in Malaysia for approximately RM 34.210 million (approximately ₹83 crores). The company has made an incremental provision of ₹7.11 crores towards gratuity for the quarter and nine months ended December 31, 2025, due to the new Labour Codes.
In Q4FY26, the standalone revenue from operations was ₹616.3 crore, compared to ₹576.2 crore in Q4FY25, reflecting a 7.0% increase. The EBITDA stood at ₹111.3 crore, with a margin of 18.1%. The PAT was ₹90.1 crore, with a margin of 14.6%. For FY26, the standalone revenue from operations was ₹2,276.0 crore, compared to ₹2,205.2 crore in FY25, a 3.2% increase. The EBITDA was ₹411.4 crore, with a margin of 18.1%, and the PAT was ₹346.4 crore, with a margin of 15.2%.
What to do with a filing like this
Fine Organic Industries Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fine Organic Industries Limited. Read the original for the full detail.